© 2019 LENEN com pour INSTITUT DU CERVEAU TROCADERO

  • LinkedIn Social Icon
  • Twitter Social Icon
  • Google+ Social Icon

Bibliographie générale.

 
  1. Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. févr 2006;36(2):159‑65. 

  2. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. avr 2006;163(4):716‑23. 

  3. Caci HM, Morin AJ, Tran A. Prevalence and correlates of attention deficit hyperactivity disorder in adults from a French community sample. J Nerv Ment Dis. 2014;202(4):324–332. 

  4. AMoffitt TE, Houts R, Asherson P, Belsky DW, Corcoran DL, Hammerle M, et al. Is Adult ADHD a Childhood-Onset Neurodevelopmental Disorder? Evidence From a Four-Decade Longitudinal Cohort Study. Am J Psychiatry. 1 oct 2015;172(10):967‑77. 

  5. Lopez R, Micoulaud-Franchi J-A, Galera C, Dauvilliers Y. Is adult-onset attention deficit/hyperactivity disorder frequent in clinical practice? Psychiatry Res. 2017;257:238‑41. 

  6. Asherson P, Buitelaar J, Faraone SV, Rohde LA. Adult attention-deficit hyperactivity disorder: key conceptual issues. Lancet Psychiatry. juin 2016;3(6):568‑78. 

  7. Kooij JJS. Adult ADHD: Diagnostic Assessment and Treatment [Internet]. 3eéd. London: Springer-Verlag; 2013 [cité 12 déc 2018]. Disponible sur: //www.springer.com/la/book/9781447141372

  8. Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. févr 2005;35(2):245‑56.

  9. Ustun B, Adler LA, Rudin C, Faraone SV, Spencer TJ, Berglund P, et al. The World Health Organization Adult Attention-Deficit/Hyperactivity Disorder Self-Report Screening Scale for DSM-5. JAMA Psychiatry. 01 2017;74(5):520‑6. 

  10. Sobanski E. Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci. sept 2006;256 Suppl 1:i26-31. 

  11. Perroud N, Cordera P, Zimmermann J, Michalopoulos G, Bancila V, Prada P, et al. Comorbidity between attention deficit hyperactivity disorder (ADHD) and bipolar disorder in a specialized mood disorders outpatient clinic. J Affect Disord. 15 oct 2014;168:161‑6. 

  12. Estévez N, Dey M, Eich-Höchli D, Foster S, Gmel G, Mohler-Kuo M. Adult attention-deficit/hyperactivity disorder and its association with substance use and substance use disorders in young men. Epidemiol Psychiatr Sci. juin 2016;25(3):255‑66. 

  13. Quinn PD, Chang Z, Hur K, Gibbons RD, Lahey BB, Rickert ME, et al. ADHD Medication and Substance-Related Problems. Am J Psychiatry. 01 2017;174(9):877‑85. 

  14. Kaisari P, Dourish CT, Higgs S. Attention Deficit Hyperactivity Disorder (ADHD) and disordered eating behaviour: A systematic review and a framework for future research. Clin Psychol Rev. avr 2017;53:109‑21. 

  15. Barkley RA, DuPaul GJ, McMurray MB. Comprehensive evaluation of attention deficit disorder with and without hyperactivity as defined by research criteria. J Consult Clin Psychol. déc 1990;58(6):775‑89. 

  16. Davis NO, Kollins SH. Treatment for co-occurring attention deficit/hyperactivity disorder and autism spectrum disorder. Neurother J Am Soc Exp Neurother. juill 2012;9(3):518‑30. 

  17. Diaz-Roman A, Mitchell R, Cortese S. Sleep in adults with ADHD: Systematic review and meta-analysis of subjective and objective studies. Neurosci Biobehav Rev. juin 2018;89:61‑71. 

  18. Lopez R, Micoulaud-Franchi J-A, Camodeca L, Gachet M, Jaussent I, Dauvilliers Y. Association of Inattention, Hyperactivity, and Hypersomnolence in Two Clinic-Based Adult Cohorts. J Atten Disord. 1 mai 2018;1087054718775826. 

  19. Instanes JT, Klungsøyr K, Halmøy A, Fasmer OB, Haavik J. Adult ADHD and Comorbid Somatic Disease: A Systematic Literature Review. J Atten Disord. févr 2018;22(3):203‑28.  

  20. Kooij JJS, Bijlenga D, Salerno L, Jaeschke R, Bitter I, Balázs J, et al. Updated European Consensus Statement on diagnosis and treatment of adult ADHD. Eur Psychiatry. 1 févr 2019;56:14‑34. 

  21. Haute Autorité de Santé. Conduite à tenir en médecine de premier recours devant un enfant ou un adolescent susceptible d’avoir un trouble déficit de l’attention avec ou sans hyperactivité [Internet]. Saint-Denis La Plaine; 2014 [cité 12 déc 2018]. Disponible sur: https://www.has-sante.fr/portail/jcms/c_1362146/fr/conduite-a-tenir-en-medecine-de-premier-recours-devant-un-enfant-ou-un-adolescent-susceptible-d-avoir-un-trouble-deficit-de-l-attention-avec-ou-sans-hyperactivite

  22. Lopez PL, Torrente FM, Ciapponi A, Lischinsky AG, Cetkovich-Bakmas M, Rojas JI, et al. Cognitive-behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst Rev. 23 mars 2018;3:CD010840.

  23. Dentz A, Guay M-C, Parent V, Romo L. Working Memory Training for Adults With ADHD. J Atten Disord. 1 août 2017;1087054717723987.             Arns M, Batail J-

  24. M, Bioulac S, Congedo M, Daudet C, Drapier D, et al. Neurofeedback: One of today’s techniques in psychiatry? L’Encephale. avr 2017;43(2):135‑45. 

  25. Micoulaud-Franchi J-A, Geoffroy PA, Fond G, Lopez R, Bioulac S, Philip P. EEG neurofeedback treatments in children with ADHD: an updated meta-analysis of randomized controlled trials. Front Hum Neurosci. 2014;8:906. 

  26. Cunill R, Castells X, Tobias A, Capellà D. Efficacy, safety and variability in pharmacotherapy for adults with attention deficit hyperactivity disorder: a meta-analysis and meta-regression in over 9000 patients. Psychopharmacology (Berl). janv 2016;233(2):187‑97. 

  27. National Institute for Clinical Excellence. Attention deficit hyperactivity disorder: diagnosis and management | Guidance and guidelines | NICE [Internet]. 2018 [cité 27 oct 2018]. Disponible sur: https://www.nice.org.uk/guidance/ng87/chapter/Recommendations#medication

  28. Cortese S, Adamo N, Giovane CD, Mohr-Jensen C, Hayes AJ, Carucci S, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 1 sept 2018;5(9):727‑38.

  29. ANSM : Agence nationale de sécurité du médicament et des produits de santé. Méthylphénidate : données d’utilisation et de sécurité d’emploi en France - Point d’Information [Internet]. 2017 [cité 12 déc 2018]. Disponible sur: https://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/Methylphenidate-donnees-d-utilisation-et-de-securite-d-emploi-en-France-Point-d-Information